Clinical Trial Update: Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis in the Calf and/or Pedal Arteries [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Magnevist-enhanced MRA to non-contrast MRA for detecting stenosis in calf and pedal arteries has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Magnevist (gadopentetate dimeglumine)

Snippet

Sponsor: Bayer | Conditions: Stenosis | Phase 3 | Status: COMPLETED